These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7902443)

  • 1. Characterisation of Staphylococcus intermedius isolates from canine pyoderma and from healthy carriers by SDS-PAGE of exoproteins, immunoblotting and restriction endonuclease digest analysis.
    Allaker RP; Garrett N; Kent L; Noble WC; Lloyd DH
    J Med Microbiol; 1993 Dec; 39(6):429-33. PubMed ID: 7902443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of Staphylococcus intermedius carriage by healthy dogs and comparison of antimicrobial susceptibility patterns to isolates from dogs with pyoderma.
    Hartmann FA; White DG; West SE; Walker RD; Deboer DJ
    Vet Microbiol; 2005 Jun; 108(1-2):119-31. PubMed ID: 15917140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of Staphylococcus pseudintermedius isolates from atopic and healthy dogs.
    Fazakerley J; Williams N; Carter S; McEwan N; Nuttall T
    Vet Dermatol; 2010 Dec; 21(6):578-85. PubMed ID: 20456718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin G responses in 21 dogs with skin diseases to antigens from different isolates of Staphylococcus intermedius.
    Neuber AE; Thoday KL; Hill PB
    Vet Rec; 2008 Jan; 162(3):75-9. PubMed ID: 18204030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Staphylococcus intermedius from healthy dogs and cases of superficial pyoderma by DNA restriction endonuclease patterns.
    Hesselbarth J; Witte W; Cuny C; Rohde R; Amtsberg G
    Vet Microbiol; 1994 Aug; 41(3):259-66. PubMed ID: 7975151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence of Staphylococcus intermedius to canine corneocytes in vitro.
    Saijonmaa-Koulumies LE; Lloyd DH
    Vet Dermatol; 2002 Aug; 13(4):169-76. PubMed ID: 12174179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of production of Staphylococcus intermedius exotoxin among clinically normal dogs, atopic dogs with recurrent pyoderma, and dogs with a single episode of pyoderma.
    Burkett G; Frank LA
    J Am Vet Med Assoc; 1998 Jul; 213(2):232-4. PubMed ID: 9676593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmission of multiple antimicrobial-resistant Staphylococcus intermedius between dogs affected by deep pyoderma and their owners.
    Guardabassi L; Loeber ME; Jacobson A
    Vet Microbiol; 2004 Jan; 98(1):23-7. PubMed ID: 14738778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections.
    Ganière JP; Médaille C; Etoré F
    Res Vet Sci; 2004 Aug; 77(1):67-71. PubMed ID: 15120955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility profiles of Staphylococcus intermedius isolates from clinical cases of canine pyoderma in South Africa.
    Blunt CA; van Vuuren M; Picard J
    J S Afr Vet Assoc; 2013 May; 84(1):E1-6. PubMed ID: 23718758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete genome sequence of the veterinary pathogen Staphylococcus pseudintermedius strain HKU10-03, isolated in a case of canine pyoderma.
    Tse H; Tsoi HW; Leung SP; Urquhart IJ; Lau SK; Woo PC; Yuen KY
    J Bacteriol; 2011 Apr; 193(7):1783-4. PubMed ID: 21278300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence of Staphylococcus intermedius to corneocytes of healthy and atopic dogs: effect of pyoderma, pruritus score, treatment and gender.
    Simou C; Thoday KL; Forsythe PJ; Hill PB
    Vet Dermatol; 2005 Dec; 16(6):385-91. PubMed ID: 16359305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of Staphylococcus schleiferi subspecies coagulans from two cases of canine pyoderma.
    Bes M; Guérin-Faublée V; Freney J; Etienne J
    Vet Rec; 2002 Apr; 150(15):487-8. PubMed ID: 11995683
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolation of exfoliative toxin from Staphylococcus intermedius and its local toxicity in dogs.
    Terauchi R; Sato H; Hasegawa T; Yamaguchi T; Aizawa C; Maehara N
    Vet Microbiol; 2003 Jun; 94(1):19-29. PubMed ID: 12742712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of Staphylococcus schleiferi from healthy dogs and dogs with otitis, pyoderma, or both.
    May ER; Hnilica KA; Frank LA; Jones RD; Bemis DA
    J Am Vet Med Assoc; 2005 Sep; 227(6):928-31. PubMed ID: 16190591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of superantigen-producing Staphylococcus intermedius isolates from canine pyoderma and proliferation-inducing potential of superantigens in dogs.
    Hendricks A; Schuberth HJ; Schueler K; Lloyd DH
    Res Vet Sci; 2002 Dec; 73(3):273-7. PubMed ID: 12443685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of Staphylococcus schleiferi from dogs with pyoderma.
    Frank LA; Kania SA; Hnilica KA; Wilkes RP; Bemis DA
    J Am Vet Med Assoc; 2003 Feb; 222(4):451-4. PubMed ID: 12597417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine superficial pyoderma and therapeutic considerations.
    Bajwa J
    Can Vet J; 2016 Feb; 57(2):204-6. PubMed ID: 26834275
    [No Abstract]   [Full Text] [Related]  

  • 19. The Staphylococcus intermedius group of bacterial pathogens: species re-classification, pathogenesis and the emergence of meticillin resistance.
    Fitzgerald JR
    Vet Dermatol; 2009 Oct; 20(5-6):490-5. PubMed ID: 20178486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial drug susceptibility of Staphylococcus intermedius clinical isolates from canine pyoderma.
    Ganiere JP; Medaille C; Mangion C
    J Vet Med B Infect Dis Vet Public Health; 2005 Feb; 52(1):25-31. PubMed ID: 15702997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.